Nephro Care India IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jun 28 to Jul 02 2024
Price Band
₹85 - 90
Current GMP
₹171 (90.0%)
Subscription
609.88 times
IPO Details
| IPO Date | June 28, 2024 to July 2, 2024 |
| Listing Date | Friday, July 5, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹85 to ₹90 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Fresh Issue | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 11,902,400 |
| Share holding post issue | 16,486,400 |
| Market Maker portion | 230,400 shares Ss Corporate Securities |
IPO Date
June 28, 2024 to July 2, 2024
Listing Date
Friday, July 5, 2024
Face Value
₹10 per share
Price Band
₹85 to ₹90 per share
Lot Size
1600 Shares
Total Issue Size
4,584,000 shares (aggregating up to ₹41.26 Cr)
Fresh Issue
4,584,000 shares (aggregating up to ₹41.26 Cr)
Issue Type
Book Built Issue IPO
Listing At
NSE SME
Share holding pre issue
11,902,400
Share holding post issue
16,486,400
Market Maker portion
230,400 shares Ss Corporate Securities
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| Qualified Institutions | 173.80 |
| Non-Institutional Buyers*** | 1,523.12 |
| Retail Investors | 562.92 |
| Total ** | 609.88 |
Anchor Investors
1
Market Maker
1
Qualified Institutions
173.80
Non-Institutional Buyers***
1,523.12
Retail Investors
562.92
Total **
609.88
Day Wise Sub
| Day | QIB | NII* | Retail | Total |
|---|---|---|---|---|
| Day 1 Jun 28, 2024 | 0.09 | 14.13 | 30.20 | 16.84 |
| Day 2 Jul 1, 2024 | 2.68 | 206.07 | 210.48 | 139.29 |
| Day 3 Jul 2, 2024 | 173.80 | 1,523.12 | 562.92 | 609.88 |
DayDay 1
Jun 28, 2024
QIB0.09
NII*14.13
Retail30.20
Total16.84
DayDay 2
Jul 1, 2024
QIB2.68
NII*206.07
Retail210.48
Total139.29
DayDay 3
Jul 2, 2024
QIB173.80
NII*1,523.12
Retail562.92
Total609.88
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 05-07-2024 | 90.00 | 175(194.44%) | 265 |
| 04-07-2024 | 90.00 | 175(194.44%) | 265 |
| 03-07-2024 | 90.00 | 235(261.11%) | 325 |
| 02-07-2024 | 90.00 | 180(200.0%) | 270 |
| 01-07-2024 | 90.00 | 155(172.22%) | 245 |
| 30-06-2024 | 90.00 | 120(133.33%) | 210 |
| 29-06-2024 | 90.00 | 120(133.33%) | 210 |
| 28-06-2024 | 90.00 | 120(133.33%) | 210 |
| 27-06-2024 | 90.00 | 100(111.11%) | 190 |
| 26-06-2024 | 90.00 | 20(22.22%) | 110 |
| 25-06-2024 | 90.00 | 0(0.0%) | 90 |
Date05-07-2024
Price90.00
GMP175(194.44%)
Estimate List Price265
Date04-07-2024
Price90.00
GMP175(194.44%)
Estimate List Price265
Date03-07-2024
Price90.00
GMP235(261.11%)
Estimate List Price325
Date02-07-2024
Price90.00
GMP180(200.0%)
Estimate List Price270
Date01-07-2024
Price90.00
GMP155(172.22%)
Estimate List Price245
Date30-06-2024
Price90.00
GMP120(133.33%)
Estimate List Price210
Date29-06-2024
Price90.00
GMP120(133.33%)
Estimate List Price210
Date28-06-2024
Price90.00
GMP120(133.33%)
Estimate List Price210
Date27-06-2024
Price90.00
GMP100(111.11%)
Estimate List Price190
Date26-06-2024
Price90.00
GMP20(22.22%)
Estimate List Price110
Date25-06-2024
Price90.00
GMP0(0.0%)
Estimate List Price90
IPO Important Dates
| IPO Open Date | Friday, June 28, 2024 |
| IPO Close Date | Tuesday, July 2, 2024 |
| Basis of Allotment | Wednesday, July 3, 2024 |
| Initiation of Refunds | Thursday, July 4, 2024 |
| Credit of Shares to Demat | Thursday, July 4, 2024 |
| Listing Date | Friday, July 5, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 2, 2024 |
IPO Open Date
Friday, June 28, 2024
IPO Close Date
Tuesday, July 2, 2024
Basis of Allotment
Wednesday, July 3, 2024
Initiation of Refunds
Thursday, July 4, 2024
Credit of Shares to Demat
Thursday, July 4, 2024
Listing Date
Friday, July 5, 2024
Cut-off time for UPI mandate confirmation
5 PM on July 2, 2024
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹144,000 |
| Retail (Max) | 1 | 1600 | ₹144,000 |
| HNI (Min) | 2 | 3,200 | ₹288,000 |
ApplicationRetail (Min)
Lots1
Shares1600
Amount₹144,000
ApplicationRetail (Max)
Lots1
Shares1600
Amount₹144,000
ApplicationHNI (Min)
Lots2
Shares3,200
Amount₹288,000
Financial Information
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 2,029.85 | 831.11 | 462.93 |
| Revenue | 1,989.60 | 1,709.51 | 342.70 |
| Profit After Tax | 340.04 | 194.24 | -0.98 |
| Net Worth | 1,392.32 | 243.76 | 49.52 |
| Reserves and Surplus | 1,332.81 | 193.76 | -0.48 |
| Total Borrowing | 246.39 | 253.74 |
Period EndedPeriod Ended
31 Dec 202331 Dec 2023
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
31 Dec 20232,029.85
31 Mar 2023831.11
31 Mar 2022462.93
Period EndedRevenue
31 Dec 20231,989.60
31 Mar 20231,709.51
31 Mar 2022342.70
Period EndedProfit After Tax
31 Dec 2023340.04
31 Mar 2023194.24
31 Mar 2022-0.98
Period EndedNet Worth
31 Dec 20231,392.32
31 Mar 2023243.76
31 Mar 202249.52
Period EndedReserves and Surplus
31 Dec 20231,332.81
31 Mar 2023193.76
31 Mar 2022-0.48
Period EndedTotal Borrowing
31 Dec 2023
31 Mar 2023246.39
31 Mar 2022253.74
Key Performance Indicator
| ROE | 41.57% |
| ROCE | 36.56% |
| RoNW | 24.42% |
| P/BV | 8.04 |
| PAT Margin (%) | 17.22 |
| EPS (Rs) | 1.63 |
ROE
41.57%
ROCE
36.56%
RoNW
24.42%
P/BV
8.04
PAT Margin (%)
17.22
EPS (Rs)
1.63
IPO Reservation
| Anchor Investor Shares Offered | 1,238,400 (27.02%) |
| Market Maker Shares Offered | 230,400 (5.03%) |
| QIB Shares Offered | 825,600 (18.01%) |
| NII (HNI) Shares Offered | 619,200 (13.51%) |
| Retail Shares Offered | 1,444,800 (31.52%) |
| Total Shares Offered | 4,584,000 (100%) |
Anchor Investor Shares Offered
1,238,400 (27.02%)
Market Maker Shares Offered
230,400 (5.03%)
QIB Shares Offered
825,600 (18.01%)
NII (HNI) Shares Offered
619,200 (13.51%)
Retail Shares Offered
1,444,800 (31.52%)
Total Shares Offered
4,584,000 (100%)
Information about company
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.
Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.
Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.
At present, Nephro Care offers the following services at its clinics:
In-house Dialysis Unit
Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology
NABL accredited inhouse Pathology
Inhouse Pharmacy
Advance diagnostic facilities
Renal Nutrition department
Home Care
Mukti (Lifestyle Support Program)
Home Dialysis
As of March 31, 2024 the hospital employs 110 people in various departments.
Objectives of IPO
The company intends to utilize the Net Fresh Issue Proceeds for the following Objects
Setting up of Multi Speciality Hospital in the name of "Vivacity Multi Specialty Hospital" (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal; and
General Corporate Expenses
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App